Company news

Impedimed Limited news in 2026

Impedimed Limited's news releases, calls and decks from 2026, newest first.

View company

Investor Presentation

October 29, 2026

Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr

October 29, 2026

Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr

October 29, 2026

Change of Director's Interest Notice - Mr Andrew Grant

October 27, 2026

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

October 27, 2026

Change of Director's Interest Notice - Ms Janelle Delaney

October 27, 2026

Change of Director's Interest Notice - Ms Fiona Bones

October 27, 2026

Application for quotation of securities - IPD

October 27, 2026

Cancer survivorship pioneer appointed to scale SOZO

October 26, 2026

Notification of Q1 FY27 Quarterly Results Investor Webinar

October 25, 2026

Change of Director's Interest Notice - Ms Janelle Delaney

October 21, 2026

Annual General Meeting - Online Meeting Guide

October 14, 2026

Notice of Annual General Meeting & Voting Form

October 14, 2026

Application for quotation of securities - IPD

October 13, 2026

Notice of Initial Substantial Holder

October 1, 2026

Change of Director's Interest Notice - Mr Erik Anderson

September 29, 2026

Update on Options

September 23, 2026

Date of 2026 Annual General Meeting

September 10, 2026

Appendix 4G and Corporate Governance Statement

August 26, 2026

2026 Annual Report

August 26, 2026

Appendix 4E

August 26, 2026

FDA Clearance for Sarcopenia Risk Assessment Received

August 18, 2026

ASX Listing Rule 7.16 Compliance

August 13, 2026

Notification of cessation of securities - IPD

August 6, 2026

Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr

July 27, 2026

Investor Presentation

July 27, 2026

Oversubscribed Share Purchase Plan Successfully Completed

June 9, 2026

CEO Business Update

June 1, 2026

Equity Raising Investor Presentation

May 4, 2026

ImpediMed announces a successful $15.2 million Capital Raise

May 3, 2026

Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr

April 29, 2026

ImpediMed Appoints Erik Anderson as Chief Executive Officer

April 7, 2026

Appointment of CEO/Managing Director

April 6, 2026

FY26 Half Year Financial Results

February 25, 2026

Appendix 4D and Interim Financial Report

February 25, 2026

ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors

February 25, 2026

Quarterly Activities Report and Appendix 4C - Dec-2025

January 28, 2026

Calls in 2026

Decks in 2026